Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block

  • Technology appraisal guidance
  • TA324
  • Published: 

Review decision – April 2018

Decision to move the existing guidance to the static list

We would like to update you on the decision made regarding the review of the existing guidance on TA324; Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block.

No new evidence has been published since NICE technology appraisal guidance 324 that is likely to lead to a change in the existing recommendations.

Consequently NICE’s Guidance Executive has decided that TA324 should move to the ‘static list’ of technology appraisals without consultation.

Review decision paper

This page was last updated: